{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:59:49Z","timestamp":1773802789947,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300580"],"award-info":[{"award-number":["82300580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04667-y","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:27:07Z","timestamp":1770791227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Sha","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buer","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"4667_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","volume":"16","author":"H You","year":"2022","unstructured":"You H, Ma X, Efe C, et al. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int. 2022;16:1\u201323.","journal-title":"Hepatol Int"},{"key":"4667_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gut.20.2.137","volume":"20","author":"JM Shapiro","year":"1979","unstructured":"Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979;20:137\u201340.","journal-title":"Gut"},{"key":"4667_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hep.510290140","volume":"29","author":"AM Bonnand","year":"1999","unstructured":"Bonnand AM, Heathcote EJ, Lindor KD, et al. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Hepatology. 1999;29:39\u201343.","journal-title":"Hepatology"},{"key":"4667_CR4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","volume":"147","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, van Buuren HR, Hirschfield GM, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology. 2014;147:1338\u201349. e1335.","journal-title":"Gastroenterology"},{"key":"4667_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12072-017-9819-9","volume":"11","author":"S Chen","year":"2017","unstructured":"Chen S, Duan W, You H, et al. A brief review on prognostic models of primary biliary cholangitis. Hepatol Int. 2017;11:412\u20138.","journal-title":"Hepatol Int"},{"key":"4667_CR6","unstructured":"Grant LM, Faust TW, Thoguluva Chandrasekar V, et al. Gilbert Syndrome. In: StatPearls. Treasure Island (FL) ineligible companies, 2024. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29262099\/."},{"key":"4667_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","volume":"115","author":"CF Murillo Perez","year":"2020","unstructured":"Murillo Perez CF, Harms MH, Lindor KD, et al. Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase. Am J Gastroenterol. 2020;115:1066\u201374.","journal-title":"Am J Gastroenterol"},{"key":"4667_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/HEP.0000000000000529","volume":"79","author":"C Corpechot","year":"2024","unstructured":"Corpechot C, Lemoinne S, Soret PA, et al. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: to what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival. gain? Hepatol. 2024;79:39\u201348.","journal-title":"gain? Hepatol"},{"key":"4667_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"4667_CR10","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105:2186\u201394.","journal-title":"Am J Gastroenterol"},{"key":"4667_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/kjhep.2012.18.1.1","volume":"18","author":"KT Suk","year":"2012","unstructured":"Suk KT, Baik SK, Yoon JH, et al. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1\u201321.","journal-title":"Korean J Hepatol"},{"key":"4667_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, European Association for the Study of the Liver. Clinical management of hepatocellular carcinoma. J Hepatol. 2001;35:421\u201330. Conclusions of the Barcelona-2000 EASL conference.","journal-title":"J Hepatol"},{"key":"4667_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871\u20137.","journal-title":"Hepatology"},{"key":"4667_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouilleres O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361\u20137.","journal-title":"J Hepatol"},{"key":"4667_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1478-3231.2011.02678.x","volume":"32","author":"N Momah","year":"2012","unstructured":"Momah N, Silveira MG, Jorgensen R, et al. Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis. Liver Int. 2012;32:790\u20135.","journal-title":"Liver Int"},{"key":"4667_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper EM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136:1281\u20137.","journal-title":"Gastroenterology"},{"key":"4667_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/jgh.12938","volume":"30","author":"AW Chan","year":"2015","unstructured":"Chan AW, Chan RC, Wong GL, et al. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score. J Gastroenterol Hepatol. 2015;30:1391\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"4667_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930\u201350.","journal-title":"Hepatology"},{"key":"4667_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0016-5085(84)90705-4","volume":"87","author":"M Muraca","year":"1984","unstructured":"Muraca M, Fevery J. Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver. Gastroenterology. 1984;87:308\u201313.","journal-title":"Gastroenterology"},{"key":"4667_CR20","doi-asserted-by":"publisher","first-page":"d2293","DOI":"10.1136\/bmj.d2293","volume":"342","author":"LC Claridge","year":"2011","unstructured":"Claridge LC, Armstrong MJ, Booth C, et al. Gilbert\u2019s syndrome. BMJ. 2011;342:d2293.","journal-title":"BMJ"},{"key":"4667_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.5009\/gnl20171","volume":"15","author":"HA Lee","year":"2021","unstructured":"Lee HA, Jung JY, Lee YS, et al. Direct bilirubin is more valuable than total bilirubin for predicting prognosis in patients with liver cirrhosis. Gut Liver. 2021;15:599\u2013605.","journal-title":"Gut Liver"},{"key":"4667_CR22","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","volume":"21","author":"C Levy","year":"2023","unstructured":"Levy C, Manns M, Hirschfield G. New treatment paradigms in primary biliary cholangitis. Clin Gastroenterol Hepatol. 2023;21:2076\u201387.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04667-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:02:50Z","timestamp":1773795770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4667"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04667-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The ethics committee of the Beijing Friendship Hospital, Capital Medical University reviewed and approved the study.All patients provided verbal informed consent prior to their inclusion in the study, as approved by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}